You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus

Article info

Article menu
Co-morbidities
Original research
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus

Authors

  • Sebastian Bruera Section of Allergy, Immunology, and Rheumatology, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Xiudong Lei Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Hui Zhao Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jinoos Yazdany University of California at San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Mariana Chavez-MacGregor Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Sharon H Giordano Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Maria E Suarez-Almazor Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Maria E Suarez-Almazor; msalmazor{at}mdanderson.org
View Full Text

Citation

Bruera S, Lei X, Zhao H, et al
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
Lupus Science & Medicine 2023;10:e000750. doi: 10.1136/lupus-2022-000750

Publication history

  • Received June 10, 2022
  • Accepted December 11, 2022
  • First published February 14, 2023.
Online issue publication 
August 02, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.